Featured Articles

  1. Can Optimized Cardiology Trials Solve Major Challenges? 6/18/2024

    Discover the key challenges facing cardiology today, explore the benefits of optimized trials, and learn how they effectively address critical issues.

  2. Improving Diversity: Patient Engagement And Recruitment Services 5/13/2024

    Per FDORA, sponsors must submit diversity action plans for FDA approval. Luckily, these plans are easy to implement with this Patient Engagement and Recruitment solution.

  3. 3 Steps For Internal Or Family Medicine Clinical Trials Enrollment 4/17/2024

    If 25% of U.S. adults don’t have a primary care provider, how can you access enough patients to fill your internal or family medicine clinical trial? Here are three tips.

  4. Patient Engagement: Early Cancer Detection Blood Draw 4/17/2024

    Discover how we aided a pharmaceutical company in enrolling participants for a Phase III trial, DETECT-ASCEND 2, focused on Plasma-Based CancerSEEK Testing for early cancer detection.

  5. Can Patient-Led Clinical Trial Design Save Neurology Research? 4/17/2024

    What is causing high fail rates, and what are the best opportunities for sponsors to turn them around? See how understanding the factors can help sponsors navigate and improve outcomes in neurology clinical trials.

  6. Solutions To Clinical Trial Travel 3/25/2024

    Read why the increase in travel distance, time, and frequency suggests patient travel is a bigger barrier to patient recruitment and retention than the industry previously thought.

  7. Will FDORA Impact My Clinical Research Practice? 12/18/2023

    Explore the details of each provision of the FDA Omnibus Reform Act of 2022 to better understand and navigate the evolving regulatory framework, ensuring compliance and optimal functioning in the realm of clinical trials.

  8. 3 Strategies For Increasing Diversity In Psychedelic Research 11/13/2023

    Psychedelic research has about 18.4% total minority participation—less than half of the average 38.2% country-level representation. Increase racial and ethnic diversity with these three proven strategies.

  9. The Easiest Way To Meet the FDA's Clinical Trial Diversity Requirement 10/20/2023

    Explore how this innovative approach to navigating FDORA streamlines the diversity action plan process while placing a strong emphasis on patient-centricity.

  10. Best Practices For Quality, Compliant Clinical Trials 10/20/2023

    It’s simple: Quality research is nonnegotiable. Gain insights into how teams can ensure all aspects of their trial are high quality, will withstand scrutiny, and protect the patient.